Current Environment: Production

Jessica Garbern | Medical Services

Specialties

Programs & Services

Languages

  • English

Jessica Garbern | Education

Undergraduate School

University of Michigan

Ann Arbor, MI

Graduate School

University of Washington

Seattle, WA

Medical School

University of Washington

Seattle, WA

Residency

Boston Combined Residency Program (BCRP)

Boston, MA

Residency

Boston Combined Residency Program (BCRP)

Boston, MA

Fellowship

Boston Children's Hospital

Boston, MA

Jessica Garbern | Certifications

  • American Board of Pediatrics (Cardiology)
  • American Board of Pediatrics (General)

Jessica Garbern | Publications

  1. P53 Activation Promotes Maturational Characteristics of Pluripotent Stem Cell-Derived Cardiomyocytes in 3-Dimensional Suspension Culture Via FOXO-FOXM1 Regulation. J Am Heart Assoc. 2024 Jul 02; 13(13):e033155. View P53 Activation Promotes Maturational Characteristics of Pluripotent Stem Cell-Derived Cardiomyocytes in 3-Dimensional Suspension Culture Via FOXO-FOXM1 Regulation. Abstract

  2. Discovery adductomics provides a comprehensive portrait of tissue-, age- and sex-specific DNA modifications in rodents and humans. Nucleic Acids Res. 2023 11 10; 51(20):10829-10845. View Discovery adductomics provides a comprehensive portrait of tissue-, age- and sex-specific DNA modifications in rodents and humans. Abstract

  3. Tissue-embedded stretchable nanoelectronics reveal endothelial cell-mediated electrical maturation of human 3D cardiac microtissues. Sci Adv. 2023 03 10; 9(10):eade8513. View Tissue-embedded stretchable nanoelectronics reveal endothelial cell-mediated electrical maturation of human 3D cardiac microtissues. Abstract

  4. Senescence mechanisms and targets in the heart. Cardiovasc Res. 2022 03 25; 118(5):1173-1187. View Senescence mechanisms and targets in the heart. Abstract

  5. Heart regeneration: 20 years of progress and renewed optimism. Dev Cell. 2022 02 28; 57(4):424-439. View Heart regeneration: 20 years of progress and renewed optimism. Abstract

  6. Mitochondria and metabolic transitions in cardiomyocytes: lessons from development for stem cell-derived cardiomyocytes. Stem Cell Res Ther. 2021 03 12; 12(1):177. View Mitochondria and metabolic transitions in cardiomyocytes: lessons from development for stem cell-derived cardiomyocytes. Abstract

  7. Sustained Activation of AMPK Enhances Differentiation of Human iPSC-Derived Cardiomyocytes via Sirtuin Activation. Stem Cell Reports. 2020 08 11; 15(2):498-514. View Sustained Activation of AMPK Enhances Differentiation of Human iPSC-Derived Cardiomyocytes via Sirtuin Activation. Abstract

  8. Pluripotent stem cell-derived cardiomyocytes for treatment of cardiomyopathic damage: Current concepts and future directions. Trends Cardiovasc Med. 2021 02; 31(2):85-90. View Pluripotent stem cell-derived cardiomyocytes for treatment of cardiomyopathic damage: Current concepts and future directions. Abstract

  9. Association of Clinical Rejection Versus Rejection on Protocol Biopsy With Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients. Transplantation. 2020 01; 104(1):e31-e37. View Association of Clinical Rejection Versus Rejection on Protocol Biopsy With Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients. Abstract

  10. Steady-state and regenerative hematopoiesis occurs normally in mice in the absence of GDF11. Blood. 2019 11 14; 134(20):1712-1716. View Steady-state and regenerative hematopoiesis occurs normally in mice in the absence of GDF11. Abstract

  11. Inhibition of mTOR Signaling Enhances Maturation of Cardiomyocytes Derived From Human-Induced Pluripotent Stem Cells via p53-Induced Quiescence. Circulation. 2020 01 28; 141(4):285-300. View Inhibition of mTOR Signaling Enhances Maturation of Cardiomyocytes Derived From Human-Induced Pluripotent Stem Cells via p53-Induced Quiescence. Abstract

  12. Nanoscale Technologies for Prevention and Treatment of Heart Failure: Challenges and Opportunities. Chem Rev. 2019 11 13; 119(21):11352-11390. View Nanoscale Technologies for Prevention and Treatment of Heart Failure: Challenges and Opportunities. Abstract

  13. Analysis of Cre-mediated genetic deletion of Gdf11 in cardiomyocytes of young mice. Am J Physiol Heart Circ Physiol. 2019 07 01; 317(1):H201-H212. View Analysis of Cre-mediated genetic deletion of Gdf11 in cardiomyocytes of young mice. Abstract

  14. Dysregulation of IL-33/ST2 signaling and myocardial periarteriolar fibrosis. J Mol Cell Cardiol. 2019 03; 128:179-186. View Dysregulation of IL-33/ST2 signaling and myocardial periarteriolar fibrosis. Abstract

  15. Engineering of mature human induced pluripotent stem cell-derived cardiomyocytes using substrates with multiscale topography. Advanced Functional Materials. 2018; 19(28):1707378.

  16. Into the hearts of babes: Stem cell therapy for pediatric heart failure. J Heart Lung Transplant. 2017 08; 36(8):830-832. View Into the hearts of babes: Stem cell therapy for pediatric heart failure. Abstract

  17. Is Myocarditis an Independent Risk Factor for Post-Transplant Mortality in Pediatric Heart Transplant Recipients? Circ Heart Fail. 2016 Jan; 9(1):e002328. View Is Myocarditis an Independent Risk Factor for Post-Transplant Mortality in Pediatric Heart Transplant Recipients? Abstract

  18. Cardiac stem cell therapy and the promise of heart regeneration. Cell Stem Cell. 2013 Jun 06; 12(6):689-98. View Cardiac stem cell therapy and the promise of heart regeneration. Abstract

  19. Model systems for cardiovascular regenerative biology. Cold Spring Harb Perspect Med. 2013 Apr 01; 3(4):a014019. View Model systems for cardiovascular regenerative biology. Abstract

  20. Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium. Biomaterials. 2011 Mar; 32(9):2407-16. View Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium. Abstract

  21. Injectable pH- and temperature-responsive poly(N-isopropylacrylamide-co-propylacrylic acid) copolymers for delivery of angiogenic growth factors. Biomacromolecules. 2010 Jul 12; 11(7):1833-9. View Injectable pH- and temperature-responsive poly(N-isopropylacrylamide-co-propylacrylic acid) copolymers for delivery of angiogenic growth factors. Abstract

  22. Vascular oxidative stress precedes high blood pressure in spontaneously hypertensive rats. Clin Exp Hypertens. 2005 Jan; 27(1):71-82. View Vascular oxidative stress precedes high blood pressure in spontaneously hypertensive rats. Abstract

  23. Locally enhanced angiogenesis promotes transplanted cell survival. Tissue Eng. 2004 Jan-Feb; 10(1-2):63-71. View Locally enhanced angiogenesis promotes transplanted cell survival. Abstract

BESbswy